Jacob Asset Management of New York’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
BG
NAMA
GS
AC
Jacob Asset Management of New York's CDNA Position: Q3 2023 in Review
Jacob Asset Management of New York increased its CareDx (CDNA) stake by 105% in Q3 2023, buying an estimated $238K and bringing the position to 50,260 shares worth $352K. The position accounts for 0.5% of the portfolio, ranked #49.
Jacob Asset Management of New York first reported a position in CDNA in Q4 2020 and has held it in 12 quarters since. The position peaked at $381K in Q1 2022. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.
- Jacob Asset Management of New York held 50,260 shares of CareDx worth $352K as of Q3 2023.
- Jacob Asset Management of New York bought 25,795 CareDx shares in Q3 2023, an estimated $238K.
- CareDx made up 0.5% of Jacob Asset Management of New York's portfolio in Q3 2023, its #49 holding.
- Jacob Asset Management of New York first reported a position in CareDx in Q4 2020 and has held it in 12 quarters since.
- Jacob Asset Management of New York's CareDx position peaked at $381K in Q1 2022.
- 150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.
Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.